GENYO (Pfizer-University of Granada-Andalusian Government Centre for Genomics and Oncological Research), Armilla, Granada, Spain.
Cancer Res. 2010 Jun 1;70(11):4676-86. doi: 10.1158/0008-5472.CAN-09-4197. Epub 2010 May 18.
Cancer stem cells have been hypothesized to explain tumor plasticity, including the capability to adopt distinct differentiation commitments. Among the mechanisms of tumor neovascularization, the ability of some malignant cells to mimic an endothelial phenotype has been recognized by a capacity to form matrix-enriched pseudovascular structures. In addition to the expression of genes associated with an endothelial nature, the molecular dynamism of specific microenvironments may also be critical. Here, we report the identification of the extracellular protease ADAMTS1 as a critical molecule for tumor cells to acquire endothelial-like properties. In a fibrosarcoma model, ADAMTS1 increased tumor growth rate in an angiogenesis-independent manner, influencing the tumor cells to display an exclusive endothelial-like gene signature. We documented the relevant expression of ADAMTS1 in aggressive and highly plastic melanoma and Ewing sarcoma cells. Notably, inhibiting ADAMTS1 action compromised the endothelial mimetic attributes observed in this setting. Our findings provide insights into how the tumor microenvironment can elicit endothelial mimicry by tumor cells.
癌症干细胞被假设可以解释肿瘤的可塑性,包括采用不同分化承诺的能力。在肿瘤血管生成的机制中,一些恶性细胞通过形成富含基质的假血管结构来模拟内皮表型的能力已被认识到。除了表达与内皮特性相关的基因外,特定微环境的分子动态变化也可能至关重要。在这里,我们报告了细胞外蛋白酶 ADAMTS1 的鉴定,作为肿瘤细胞获得内皮样特性的关键分子。在纤维肉瘤模型中,ADAMTS1 以非血管生成依赖的方式增加了肿瘤的生长速度,影响肿瘤细胞表现出独特的内皮样基因特征。我们记录了 ADAMTS1 在侵袭性和高度可塑性的黑色素瘤和尤文肉瘤细胞中的相关表达。值得注意的是,抑制 ADAMTS1 的作用削弱了在这种情况下观察到的内皮模拟特性。我们的发现提供了深入了解肿瘤微环境如何通过肿瘤细胞引发内皮模拟的见解。